Join Schlafender Hase on September 14th, as we guide you through the typical steps needed to properly identify the right tool for your organization and how to get it approved.
Digital transformation is all the rage these days, but what does that actually mean for professionals working with regulated content in Pharma and Med Device, and more importantly, what does it mean for you?
Join us on November 10th as we explore the why and how of a digital proofreading workflow.
Join Schlafender Hase as we discuss the challenges faced by life science companies when it comes to ensuring the accuracy of all digital and printed material and how technology can play an integral role in improving this process.
AI is already being used in many Life Science applications, meanwhile, Health Authorities are looking to regulate the use of AI. As a regulatory affairs professional, it is essential to have an understanding of this technology.
In this general introduction to the field of AI, different uses of the term “Artificial Intelligence” will be discussed, and which might be desirable in a given context.
Digital transformation is all the rage these days, but what does that actually mean for professionals working with regulated content in Pharma and Med Device, and more importantly, what does it mean for you?
Join us on November 10th as we explore the why and how of a digital proofreading workflow.
Just when you thought TVT couldn’t get any better, TVT 11, the most powerful version ever is set to be released on November 8th 2022.
Providing patients and Health Care Practitioners with electronically delivered e-Labelling is becoming increasingly important. Several Regulatory Authorities now permit and encourage online e-PIL content, with other regions following suit.
Ensuring content is delivered accurately in print and online formats, will be vital to ensuring patient safety, especially during the complex transition phase from printed-paper to electronic patient information.
This webinar will help companies understand the nuances of global health authority drug product labeling requirements.
This responsibility – to get everything right – often falls on Regulatory Affairs where the workload is high, and deadlines are short.
